{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:28Z","timestamp":1791925708735,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32-GM007171"],"award-info":[{"award-number":["T32-GM007171"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.brainres.2020.146685","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T11:45:59Z","timestamp":1580384759000},"page":"146685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["ApoE mimetic improves pathology and memory in a model of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"1733","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2740-1248","authenticated-orcid":false,"given":"Kamesh","family":"Krishnamurthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Cantillana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Kolls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Laskowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8974","key":"10.1016\/j.brainres.2020.146685_b0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(95)91411-0","article-title":"ApoE genotype and survival from intracerebral haemorrhage","volume":"346","author":"Alberts","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.brainres.2020.146685_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2796.2004.01386.x","article-title":"Multiple cognitive deficits during the transition to Alzheimer's disease","volume":"256","author":"B\u00e4ckman","year":"2004","journal-title":"J. Internal Med."},{"key":"10.1016\/j.brainres.2020.146685_bib252","doi-asserted-by":"crossref","DOI":"10.1038\/341162a0","article-title":"The LDL\u2013receptor\u2013related protein, LRP, is an apolipoprotein E-binding protein","author":"Beisegel","year":"1989","journal-title":"Nature"},{"issue":"7399","key":"10.1016\/j.brainres.2020.146685_b0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2020.146685_b0020","first-page":"325","article-title":"Alzheimer disease","volume":"Vol. 145","author":"Calderon-Garcidue\u00f1as","year":"2018"},{"issue":"39","key":"10.1016\/j.brainres.2020.146685_b0030","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1523\/JNEUROSCI.2693-05.2005","article-title":"Acute \u03b3-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease","volume":"25","author":"Comery","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2020.146685_bib257","doi-asserted-by":"crossref","DOI":"10.1101\/lm.51002","article-title":"Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer\u2019s disease","author":"Corcoran","year":"2002","journal-title":"Learn. Memory"},{"issue":"16","key":"10.1016\/j.brainres.2020.146685_b0035","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/01.wnl.0000295996.54210.69","article-title":"Disease-modifying therapies for Alzheimer disease: challenges to early intervention","volume":"69","author":"Cummings","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"Ne. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.brainres.2020.146685_b0050","article-title":"Alzheimer disease: pharmacologic and nonpharmacologic therapies for cognitive and functional symptoms","volume":"95","author":"Epperly","year":"2017","journal-title":"Am. Fam. Phys."},{"issue":"5","key":"10.1016\/j.brainres.2020.146685_b0055","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.410380515","article-title":"Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives","volume":"38","author":"Farrer","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2020.146685_bib258","article-title":"Apolipoprotein E-\u03b54 genotype predicts a poor outcome in survivors of traumatic brain injury","author":"Friedman","year":"1999","journal-title":"Neurology"},{"issue":"6514","key":"10.1016\/j.brainres.2020.146685_b0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.brainres.2020.146685_b0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1749-6632.2010.05726.x","article-title":"Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials","volume":"1207","author":"Gorelick","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2020.146685_b0070","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/jcph.853","article-title":"Phase 1 randomized, double-blind, placebo-controlled study to determine the safety, tolerability, and pharmacokinetics of a single escalating dose and repeated doses of CN-105 in healthy adult subjects","volume":"57","author":"Guptill","year":"2017","journal-title":"J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.brainres.2020.146685_b0075","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0028-3932(01)00223-8","article-title":"Impaired fear conditioning in Alzheimer\u2019s disease","volume":"40","author":"Hamann","year":"2002","journal-title":"Neuropsychologia"},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.brainres.2020.146685_b0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: a multifunctional scavenger and signaling receptor","volume":"108","author":"Herz","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.brainres.2020.146685_b0090","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00004647-200003000-00003","article-title":"Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice","volume":"20","author":"Horsburgh","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2020.146685_bib266","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3773-11.2011","article-title":"Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-\u03b2 amyloidosis","author":"Kim","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2020.146685_bib255","article-title":"Soluble A\u03b2 oligomer production and toxicity","author":"Larson","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2020.146685_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0404.2006.00680.x","article-title":"Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease","volume":"114","author":"Laskowitz","year":"2006","journal-title":"Acta Neurol. Scand."},{"issue":"7","key":"10.1016\/j.brainres.2020.146685_b0105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00004647-199707000-00005","article-title":"Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia","volume":"17","author":"Laskowitz","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"11","key":"10.1016\/j.brainres.2020.146685_b0110","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1089\/neu.2010.1396","article-title":"Traumatic brain injury exacerbates neurodegenerative pathology: improvement with an apolipoprotein E-based therapeutic","volume":"27","author":"Laskowitz","year":"2010","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.brainres.2020.146685_b0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/exnr.2001.7541","article-title":"Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides","volume":"167","author":"Laskowitz","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2020.146685_b0120","doi-asserted-by":"crossref","first-page":"46461","DOI":"10.1038\/srep46461","article-title":"Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model","volume":"7","author":"Laskowitz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2020.146685_b0125","doi-asserted-by":"crossref","first-page":"34834","DOI":"10.1038\/srep34834","article-title":"Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage","volume":"6","author":"Lei","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.brainres.2020.146685_b0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/svn-2018-000152","article-title":"Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH","volume":"3","author":"Liu","year":"2018","journal-title":"Stroke Vasc. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2020.146685_b0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ana.10098","article-title":"Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema","volume":"51","author":"Lynch","year":"2002","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.brainres.2020.146685_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132604","article-title":"Characterization of novel Src family kinase inhibitors to attenuate microgliosis","volume":"10","author":"Manocha","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.brainres.2020.146685_b0150","doi-asserted-by":"crossref","first-page":"p.CNC32","DOI":"10.2217\/cnc-2016-0031","article-title":"Animal models of chronic traumatic encephalopathy","volume":"2","author":"McAteer","year":"2017","journal-title":"Concussion"},{"key":"10.1016\/j.brainres.2020.146685_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/S0304-3940(98)00286-9","article-title":"High frequency of apolipoprotein E \u220a2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage.","author":"McCarron","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2020.146685_bib262","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.57.1.89","article-title":"A gender difference in the association between APOE genotype and age-related cognitive decline","author":"Mortensen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2020.146685_b0155","first-page":"1","article-title":"Understanding the role of ApoE fragments in Alzheimer\u2019s disease","author":"Mu\u00f1oz","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2020.146685_bib251","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2014.00349","article-title":"An open-source toolbox for automated phenotyping of mice in behavioral tasks","author":"Patel","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2020.146685_bib256","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits A\u03b2 production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models","author":"Qing","year":"2008","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.brainres.2020.146685_b0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-130716","article-title":"Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele","volume":"37","author":"Qiu","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2020.146685_bib264","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.95.18.10914","article-title":"Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females.","author":"Raber","year":"1998","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"10.1016\/j.brainres.2020.146685_b0170","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2003.12.023","article-title":"ApoE genotype accounts for the vast majority of AD risk and AD pathology","volume":"25","author":"Raber","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.brainres.2020.146685_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2018.07.216","article-title":"Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study","volume":"15","author":"Rajan","year":"2019","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.brainres.2020.146685_bib265","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/531326","article-title":"Sex differences in presynaptic density and neurogenesis in middle-aged ApoE4 and ApoE knockout mice.","author":"Rijpma","year":"2013","journal-title":"J. Neurodegenerative Dis."},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics J."},{"issue":"6","key":"10.1016\/j.brainres.2020.146685_b0185","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0958-1669(94)90091-4","article-title":"APOE is a major susceptibility gene for Alzheimer's disease","volume":"5","author":"Roses","year":"1994","journal-title":"Curr. Opin. Biotechnol."},{"issue":"7","key":"10.1016\/j.brainres.2020.146685_b0190","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2174\/13892037113149990144","article-title":"CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study","volume":"10","author":"Ross","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0195","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2020.146685_bib260","doi-asserted-by":"crossref","DOI":"10.1038\/nm0995-852","article-title":"ApoE as a prognostic factor for post\u2013traumatic coma","author":"Sorbi","year":"1995","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.brainres.2020.146685_b0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2020.146685_bib253","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.272.29.17972","article-title":"Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis","author":"Sullivan","year":"1997","journal-title":"J Biol. Chem."},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/jnc.13072","article-title":"APOE-modulated A\u03b2-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective","volume":"133","author":"Tai","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2020.146685_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(97)04318-3","article-title":"Association of apolipoprotein E polymorphism with outcome after head injury","author":"Teasdale","year":"1997","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/acn3.399","article-title":"Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke","volume":"4","author":"Tu","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2020.146685_b0215","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11682-013-9272-x","article-title":"Apolipoprotein E, gender, and Alzheimer\u2019s disease: an overlooked, but potent and promising interaction","volume":"8","author":"Ungar","year":"2014","journal-title":"Brain Imaging Behav."},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/lm.5.4.391","article-title":"Automated measurement of mouse freezing behavior and its use for quantitative trait locus analysis of contextual fear conditioning in (BALB\/cJ\u00d7 C57BL\/6J) F2 mice","volume":"5","author":"Valentinuzzi","year":"1998","journal-title":"Learn. Memory"},{"issue":"1\u20134","key":"10.1016\/j.brainres.2020.146685_b0225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000334914","article-title":"APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer\u2019s disease transgenics","volume":"10","author":"Vitek","year":"2012","journal-title":"Neurodegen. Dis."},{"issue":"2","key":"10.1016\/j.brainres.2020.146685_b0235","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain A\u03b2 distinguish Alzheimer's disease from normal and pathologic aging","volume":"158","author":"Wang","year":"1999","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.brainres.2020.146685_b0250","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/neu.2007.0489","article-title":"Meta-analysis of APOE 4 allele and outcome after traumatic brain injury","volume":"25","author":"Zhou","year":"2008","journal-title":"J. Neurotrauma"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689932030041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689932030041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:03:41Z","timestamp":1762103021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689932030041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":57,"alternative-id":["S000689932030041X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2020.146685","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ApoE mimetic improves pathology and memory in a model of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2020.146685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"146685"}}